Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (VTGN)

Q: What does CUSIP 92840H400 represent in this 13F holders report?

CUSIP 92840H400 is the security identifier for VTGN - Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held VTGN - Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share in Q1 2025?

47 institutional investors reported VTGN - Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share for Q1 2025. Use the holders table for investor-level position and value details.

CUSIP: 92840H400

Q1 2025 13F Holders as of 31 Mar 2025

Security type / class: Equity / Common Stock, par value $0.001 per share
Total 13F shares: 15,325,061
Total 13F value: $38,287,272
Share change: +421,207
Put/Call ratio: 13%
SEC-reported price per share: $2.50
Number of holders: 47
Value change: +$856,836
Number of buys: 14
Number of sells: 28
Shares outstanding: 41,041,331

Security key

92840H400

Report period

Q1 2025

Institutions

Top holders

VTGN full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2026 Vistagen Therapeutics, Inc. SEC filings Vistagen Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 92840H400

Newer quarter: Q2 2026

Recent filing periods:

Q2 2026

Ownership snapshot

Top reported holders of VTGN - Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

BIOTECHNOLOGY VALUE FUND L P

Disclosed value leader

TCG Crossover Management,...

Comparable rows

15/15

Latest evidence

31 Dec 2024

13D/G 13F 3/4/5 Lead comparable stake: 10% 13D/G row: BIOTECHNOLOGY VALUE FUND L P Showing 1-6 of 15 holder rows.

Quick read

BIOTECHNOLOGY VALUE FUND L P leads the comparable SEC ownership view at 10%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BIOTECHNOLOGY VALUE FUND L P's linked filing trail.

Comparable ownership Top 5

BIOTECHNOLOGY VALUE FUND L P 10%

TCG Crossover Management, LLC 6.5%

STEMPOINT CAPITAL LP 5.7%

VANGUARD GROUP INC 4.9%

Nantahala Capital Management, LLC 4.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
BIOTECHNOLOGY VALUE FUND L P	13D/G BVF PARTNERS L P/IL 13D/G	10%	$7,217,318 3,084,324 shares	$0	31 Dec 2024
TCG Crossover Management, LLC	13F Company 13F	6.5%	$7,895,911 2,676,580 shares	—	31 Dec 2024
STEMPOINT CAPITAL LP	13F Company 13F	5.7%	$5,946,790 2,328,492 shares	—	31 Dec 2024
VANGUARD GROUP INC	13F Company 13F	4.9%	$5,960,036 2,020,351 shares	—	31 Dec 2024
Nantahala Capital Management, LLC	13F Company 13F	4.8%	$5,846,841 1,981,980 shares	—	31 Dec 2024
Commodore Capital LP	13F 3/4/5 Company · 10%+ Owner 13F 3/4/5	3.8%	$4,646,250 1,575,000 shares	—	31 Dec 2024

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

15,325,061

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2025 vs Q1 2025 Across Filers

Q1 2025 holders

Holder diff

Investor	Q1 2025 Shares	Q1 2025 Shares	Share Diff	Share Chg %	Q1 2025 value	Q1 2025 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend